Activation of PPAR-δ induces microRNA-100 and decreases the uptake of very low-density lipoprotein in endothelial cells

British Journal of Pharmacology

Volumn 172, Issue 15, 2015, Pages 3728-3736

  Fang, Xi ^a,b   Fang, Li ^a   Liu, Ao ^a   Wang, Xiaohong ^a   Zhao, Beilei ^a   Wang, Nanping ^a,b  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARGONAUTE 1 PROTEIN; MESSENGER RNA; MICRORNA 100; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; VERY LOW DENSITY LIPOPROTEIN; VERY LOW DENSITY LIPOPROTEIN RECEPTOR; [2 METHYL 4 [4 METHYL 2 (4 TRIFLUOROMETHYLPHENYL) 5 THIAZOLYLMETHYLTHIO]PHENOXY]ACETIC ACID; LOW DENSITY LIPOPROTEIN RECEPTOR; MICRORNA; MIRN100 MICRORNA, HUMAN; THIAZOLE DERIVATIVE;

3' UNTRANSLATED REGION; ARTICLE; BIOINFORMATICS; CONTROLLED STUDY; FLUORESCENCE ANALYSIS; GENE EXPRESSION; GENE INDUCTION; GENE TARGETING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LIPID TRANSPORT; LIPOPROTEIN METABOLISM; LUCIFERASE ASSAY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTECTION; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECEPTOR UPREGULATION; UMBILICAL VEIN ENDOTHELIAL CELL; AGONISTS; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; CELL CULTURE; DRUG EFFECTS; ENDOTHELIUM CELL; METABOLISM; PHYSIOLOGY;

CELLS, CULTURED; ENDOTHELIAL CELLS; HUMANS; LIPOPROTEINS, VLDL; MICRORNAS; PPAR DELTA; RECEPTORS, LDL; THIAZOLES;

EID: 84937019728     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/bph.13160     Document Type: Article

References (36)

1. Alexander SP, Benson HE, Faccenda E, Pawson AJ, Sharman JL, Spedding M, et al. (2013a). The Concise Guide to PHARMACOLOGY 2013/14: nuclear hormone receptors. Br J Pharmacol 170: 1652-1675.
2. Alexander SPH, Benson HE, Faccenda E, Pawson AJ, Sharman JL, Spedding M, et al. (2013b). The Concise Guide to PHARMACOLOGY 2013/14: Transporters. Br J Pharmacol 170: 1706-1796.
3. Barish GD, Atkins AR, Downes M, Olson P, Chong LW, Nelson M, et al. (2008). PPARdelta regulates multiple proinflammatory pathways to suppress atherosclerosis. Proc Natl Acad Sci U S A 105: 4271-4276.
4. Carroll MD, Lacher DA, Sorlie PD, Cleeman JI, Gordon DJ, Wolz M, et al. (2005). Trends in serum lipids and lipoproteins of adults, 1960-2002. JAMA 294: 1773-1781.
5. Chawla A, (2003). PPARdelta is a very low-density lipoprotein sensor in macrophages. Proc Natl Acad Sci U S A 100: 1268-1273.
6. Chen Z, Lai TC, Jan YH, Lin FM, Wang WC, Xiao H, et al. (2013). Hypoxia-responsive miRNAs target argonaute 1 to promote angiogenesis. J Clin Invest 123: 1057-1067.
7. Eck MV, Oost J, Goudriaan JR, Hoekstra M, Hildebrand RB, Bos IS, et al. (2005). Role of the macrophage very-low-density lipoprotein receptor in atherosclerotic lesion development. Atherosclerosis 183: 230-237.
8. Eiselein L, Wilson DW, Lame MW, Rutledge JC, (2007). Lipolysis products from triglyceride-rich lipoproteins increase endothelial permeability, perturb zonula occludens-1 and F-actin, and induce apoptosis. Am J Physiol Heart Circ Physiol 292: H2745-H2753.
9. Fan Y, Wang Y, Tang Z, Zhang H, Qin X, Zhu Y, et al. (2007). Suppression of pro-inflammatory adhesion molecules by PPAR- in human vascular endothelial cells. Arterioscler Thromb Vasc Biol 28: 315-321.
10. Filipowicz W, Bhattacharyya SN, Sonenberg N, (2008). Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet 9: 102-114.
11. Graham TL, Mookherjee C, Suckling KE, Palmer CN, Patel L, (2005). The PPARdelta agonist GW0742X reduces atherosclerosis in LDLR(-/-) mice. Atherosclerosis 181: 29-37.
12. Grundmann S, Hans FP, Kinniry S, Heinke J, Helbing T, Bluhm F, et al. (2011). MicroRNA-100 regulates neovascularization by suppression of mammalian target of rapamycin in endothelial and vascular smooth muscle cells. Circulation 123: 999-1009.
13. Hiltunen TP, Luoma JS, Nikkari T, Yla-Herttuala S, (1998). Expression of LDL receptor, VLDL receptor, LDL receptor-related protein, and scavenger receptor in rabbit atherosclerotic lesions: marked induction of scavenger receptor and VLDL receptor expression during lesion development. Circulation 97: 1079-1086.
14. Hodis HN, (1999). Triglyceride-rich lipoprotein remnant particles and risk of atherosclerosis. Circulation 99: 2852-2854.
15. Karls U, Muller U, Gilbert DJ, Copeland NG, Jenkins NA, Harbers K, (1992). Structure, expression, and chromosome location of the gene for the beta subunit of brain-specific Ca2+/calmodulin-dependent protein kinase II identified by transgene integration in an embryonic lethal mouse mutant. Mol Cell Biol 12: 3644-3652.
16. Khan AA, Betel D, Miller ML, Sander C, Leslie CS, Marks DS, (2009). Transfection of small RNAs globally perturbs gene regulation by endogenous microRNAs. Nat Biotechnol 27: 549-555.
17. Kugiyama K, Doi H, Takazoe K, Kawano H, Soejima H, Mizuno Y, et al. (1999). Remnant lipoprotein levels in fasting serum predict coronary events in patients with coronary artery disease. Circulation 99: 2858-2860.
18. Laible M, Boonrod K, (2009). Homemade site directed mutagenesis of whole plasmids. J Vis Exp 27: 1135.
19. Lee CH, Olson P, Hevener A, Mehl I, Chong LW, Olefsky JM, et al. (2006). PPAR regulates glucose metabolism and insulin sensitivity. Proc Natl Acad Sci U S A 103: 3444-3449.
20. Li AC, Binder CJ, Gutierrez A, Brown KK, Plotkin CR, Pattison JW, et al. (2004). Differential inhibition of macrophage foam-cell formation and atherosclerosis in mice by PPARalpha, beta/delta, and gamma. J Clin Invest 114: 1564-1576.
21. Libby P, (2007). Fat fuels the flame: triglyceride-rich lipoproteins and arterial inflammation. Circ Res 100: 299-301.
22. Liou JY, Lee S, Ghelani D, Matijevic-Aleksic N, Wu KK, (2006). Protection of endothelial survival by peroxisome proliferator-activated receptor-delta mediated 14-3-3 upregulation. Arterioscler Thromb Vasc Biol 26: 1481-1487.
23. Miller M, Stone NJ, Ballantyne C, Bittner V, Criqui MH, Ginsberg HN, et al. (2011). Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association. Circulation 123: 2292-2333.
24. Nordestgaard BG, Benn M, Schnohr P, Tybjaerg-Hansen A, (2007). Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. JAMA 298: 299-308.
25. Oliver WR Jr, Shenk JL, Snaith MR, Russell CS, Plunket KD, Bodkin NL, et al. (2001). A selective peroxisome proliferator-activated receptor delta agonist promotes reverse cholesterol transport. Proc Natl Acad Sci U S A 98: 5306-5311.
26. Pawson AJ, Sharman JL, Benson HE, Faccenda E, Alexander SP, Buneman OP, et al.; NC-IUPHAR (2014). The IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledge base of drug targets and their ligands. Nucl Acids Res 42 (Database Issue): D1098-D1106.
27. Qin X, Tian J, Zhang P, Fan Y, Chen L, Guan Y, et al. (2007). Laminar shear stress up-regulates the expression of stearoyl-CoA desaturase-1 in vascular endothelial cells. Cardiovasc Res 74: 506-514.
28. Qin X, Xie X, Fan Y, Tian J, Guan Y, Wang X, et al. (2008). Peroxisome proliferator-activated receptor-δ induces insulin-induced gene-1 and suppresses hepatic lipogenesis in obese diabetic mice. Hepatology 48: 432-441.
29. Takahashi S, Kawarabayasi Y, Nakai T, Sakai J, Yamamoto T, (1992). Rabbit very low density lipoprotein receptor: a low density lipoprotein receptor-like protein with distinct ligand specificity. Proc Natl Acad Sci U S A 89: 9252-9256.
30. Tanaka T, Yamamoto J, Iwasaki S, Asaba H, Hamura H, Ikeda Y, et al. (2003). Activation of peroxisome proliferator-activated receptor delta induces fatty acid beta-oxidation in skeletal muscle and attenuates metabolic syndrome. Proc Natl Acad Sci U S A 100: 15924-15929.
31. Tian XY, Wong WT, Wang N, Lu Y, Cheang WS, Liu J, et al. (2012). PPARδ activation protects endothelial function in diabetic mice. Diabetes 61: 3285-3293.
32. Tora L, Adhikary T, Kaddatz K, Finkernagel F, Schönbauer A, Meissner W, et al. (2011). Genomewide analyses define different modes of transcriptional regulation by peroxisome proliferator-activated receptor-β/δ (PPARβ/δ). PLoS ONE 6: e16344.
33. Wang N, (2008). PPAR-delta in vascular pathophysiology. PPAR Res 2008: 164163.
34. Wang X, Fang X, Zhou J, Chen Z, Zhao B, Xiao L, et al. (2013). Shear stress activation of nuclear receptor PXR in endothelial detoxification. Proc Natl Acad Sci U S A 110: 13174-13179.
35. Wyne KL, Pathak K, Seabra MC, Hobbs HH, (1996). Expression of the VLDL receptor in endothelial cells. Arterioscler Thromb Vasc Biol 16: 407-415.
36. Yin KJ, Deng Z, Hamblin M, Xiang Y, Huang H, Zhang J, et al. (2010). Peroxisome proliferator-activated receptor regulation of miR-15a in ischemia-induced cerebral vascular endothelial injury. J Neurosci 30: 6398-6408.